Gheorghiade, M., Gattis, W. A., Barbagelata, A., Adams, K. F., Elkayam, U., Orlandi, C., … Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure Investigators. (2003). Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure. Am Heart J, 145(2 Suppl), S51–S54. https://doi.org/10.1067/mhj.2003.154

Gheorghiade, Mihai, Wendy A. Gattis, Alejandro Barbagelata, Kirkwood F. Adams, Uri Elkayam, Cesare Orlandi, Christopher M. O’Connor, and Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure Investigators. “Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure.” Am Heart J 145, no. 2 Suppl (February 2003): S51–54. https://doi.org/10.1067/mhj.2003.154.

Gheorghiade M, Gattis WA, Barbagelata A, Adams KF, Elkayam U, Orlandi C, et al. Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure. Am Heart J. 2003 Feb;145(2 Suppl):S51–4.

Gheorghiade, Mihai, et al. “Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure.” Am Heart J, vol. 145, no. 2 Suppl, Feb. 2003, pp. S51–54. Pubmed, doi:10.1067/mhj.2003.154.

Gheorghiade M, Gattis WA, Barbagelata A, Adams KF, Elkayam U, Orlandi C, O’Connor CM, Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure Investigators. Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure. Am Heart J. 2003 Feb;145(2 Suppl):S51–S54.